Michael Kolodziej, MD, has joined Flatiron Health as national medical director, Managed Care Strategy.
Michael Kolodziej, MD, has joined Flatiron Health as national medical director, Managed Care Strategy. With his blended experience of a practicing oncologist and a payer, Kolodziej will potentiate the development of alternate payment programs for community oncology clinics.
Flatiron Health, which provides technology platforms to the oncology community, has been a pathbreaker in supporting oncologists as they adapt to new reimbursement models. At Aetna, Kolodziej actively worked with community oncology practices as they developed care delivery and payment programs such as medical homes. He was also involved in establishing a value-based medical home collaboration with the University of Chicago Medicine; the pilot project, which kicked off a year back, enrolled Aetna members who were receiving treatment for breast, lung, and colon cancer at the University.
In the press release, Flatiron Health’s cofounder and chief executive officer, Nat Turner, said of Kolodziej that he “brings a wealth of expertise across providers and commercial payers, and will be critical to Flatiron Health’s strategic growth as we continue to evolve in parallel with today’s changing reimbursement environment. We are thrilled to welcome him to our team and believe his deep knowledge will enable us to further develop our innovative value-based care solution for providers facing a growing number of alternative payment programs.”
According to Kolodziej, “Flatiron Health has the technology and analytics expertise to help payers and providers streamline these complex processes, and I am honored to help guide and grow our program for the benefit of the greater oncology community.”
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More